Loading...
Nanobiotix S.A.
NANO.PA•EURONEXT
Healthcare
Biotechnology
€5.75
€0.48(9.11%)
Nanobiotix S.A. (NANO.PA) Financial Performance & Income Statement Overview
Review Nanobiotix S.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-138.62%
↓ 138.62%
Operating Income Growth
-155.39%
↓ 155.39%
Net Income Growth
-71.62%
↓ 71.62%
Operating Cash Flow Growth
-56.71%
↓ 56.71%
Operating Margin
-59.38%
↓ 59.38%
Gross Margin
106.77%
↑ 106.77%
Net Profit Margin
-79.31%
↓ 79.31%
ROE
76.53%
↑ 76.53%
ROIC
-295.43%
↓ 295.43%
Nanobiotix S.A. (NANO.PA) Income Statement & Financial Overview
Review Nanobiotix S.A.'s (NANO.PA) income statement with detailed quarterly and annual figures.
| Metric | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|
| Revenue | $9.29M | $32.91M | $3.29M | $3.45M |
| Cost of Revenue | $0.00 | -$2.86M | $740000.00 | $754000.00 |
| Gross Profit | $9.29M | $35.77M | $2.55M | $2.69M |
| Gross Profit Ratio | $1.00 | $1.09 | $0.78 | $0.78 |
| R&D Expenses | $21.99M | $20.59M | $17.22M | $15.53M |
| SG&A Expenses | $10.83M | $11.19M | $10.69M | $7.98M |
| Operating Expenses | $32.94M | $34.32M | $27.93M | $23.49M |
| Total Costs & Expenses | $32.94M | $34.32M | $28.67M | $24.25M |
| Interest Income | $0.00 | $3.40M | $3.37M | $250000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $3.11M |
| Depreciation & Amortization | $786000.00 | $274000.00 | $740000.00 | $754000.00 |
| EBITDA | -$23.24M | -$8.88M | -$25.14M | -$20.98M |
| EBITDA Ratio | -$2.50 | $0.04 | -$8.48 | -$6.82 |
| Operating Income | -$23.65M | -$1.41M | -$28.67M | -$24.25M |
| Operating Income Ratio | -$2.55 | -$0.04 | -$8.71 | -$7.03 |
| Other Income/Expenses (Net) | $1.92M | -$10.07M | -$4.33M | -$9.47M |
| Income Before Tax | -$21.73M | -$11.48M | -$29.70M | -$33.72M |
| Income Before Tax Ratio | -$2.34 | -$0.35 | -$9.02 | -$9.78 |
| Income Tax Expense | $144000.00 | $117000.00 | -$1.60M | -$3.03M |
| Net Income | -$21.87M | -$11.60M | -$28.10M | -$30.68M |
| Net Income Ratio | -$2.35 | -$0.35 | -$8.53 | -$8.90 |
| EPS | -$0.46 | -$0.31 | -$0.80 | -$0.88 |
| Diluted EPS | -$0.46 | -$0.30 | -$0.80 | -$0.88 |
| Weighted Avg Shares Outstanding | $47.12M | $37.99M | $35.04M | $34.85M |
| Weighted Avg Shares Outstanding (Diluted) | $47.12M | $38.82M | $35.04M | $34.85M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan